#VisualAbstract: Treatment of metastatic uveal melanoma with tebentafusp compared to standard treatment
Physician's Weekly,
Bookmark 1. Median overall survival and progression-free survival were greater in the tebentafusp group compared to the…
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma
Overview of attention for article published in New England Journal of Medicine, October 2023
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (91st percentile)
Mentioned by
- news
- 73 news outlets
- blogs
- 1 blog
- policy
- 2 policy sources
- 49 X users
- patent
- 2 patents
- 3 Facebook pages
- 1 Redditor
- guideline
- 5 clinical guideline sources
Readers on
- mendeley
- 178 Mendeley